Age- and disease-specific changes of the kynurenine pathway in Parkinson's and Alzheimer's disease.

J Neurochem · 2019 · PMC6899862 · PMID 31376341

Europe PMC DOI

hedged sentence

0.0160

closest p · 0.3× alpha

0.0160

boldest claim

The sentences

showed a trendp = 0.016actually significant

For AD patients, the analyses showed a trend towards reduced XA in serum of AD patients compared to control ( Z = −2.41, p = 0.016) (Fig. 2 a).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.